Saturday, Aug 08, 2020 | Last Update : 08:22 AM IST

136th Day Of Lockdown

Maharashtra49026232728117092 Tamil Nadu2850242275754690 Andhra Pradesh2069601204641842 Karnataka164924842322998 Delhi1427231282324082 Uttar Pradesh113378668341981 West Bengal89666630601954 Telangana7525753239601 Bihar7179446294400 Gujarat68855517922604 Assam5549737225132 Rajasthan4941835186763 Odisha4255028698292 Haryana4005433444467 Madhya Pradesh3729827621962 Kerala3170019147103 Jammu and Kashmir2392716218449 Punjab1901512491462 Jharkhand140705199129 Chhatisgarh10109761369 Uttarakhand8008484795 Goa7075511460 Tripura5520367528 Puducherry4147253758 Manipur301818147 Himachal Pradesh2879171013 Nagaland24056594 Arunachal Pradesh179011053 Chandigarh120671520 Meghalaya9173305 Sikkim7832971 Mizoram5022820
  World   Americas  02 Aug 2020  American countries look towards India for cheaper generic medicine

American countries look towards India for cheaper generic medicine

THE ASIAN AGE. | SRIDHAR KUMARASWAMI
Published : Aug 2, 2020, 6:41 pm IST
Updated : Aug 2, 2020, 6:41 pm IST

Ecuadorean envoy pointed out that generic medicine 'can cost up to 10 times more' in South/Latin America than in India

 India had even declared that it has remained responsible in living up to its international commitments on the supply of medicines during the pandemic which has enhanced its reputation of being the “pharmacy to the world”. (Representational Image: AFP)
  India had even declared that it has remained responsible in living up to its international commitments on the supply of medicines during the pandemic which has enhanced its reputation of being the “pharmacy to the world”. (Representational Image: AFP)

New Delhi: Looking ahead in a post-Coronavirus pandemic scenario, South/Latin American nations such as Ecuador, Brazil, Peru and Costa Rica are looking for cheaper generic pharmaceutical drugs from India which is one of the largest global producers of medicines, Ecuador’s Ambassador Hector Cueva Jacome has said.

Incidentally, the South American continent has also been badly hit by the pandemic, with south American nation Brazil currently ranking second in both the overall number of Coronavirus cases as well the death toll globally due to the pandemic, after the United States.

 

Speaking last week at a Virtual meeting organised by trade body FICCI, the Ecuador envoy Mr. Jacome said, “What is sought after is the democratisation of medicines in Latin America where many people do not have access to medicines due to their high cost.” Mr. Jacome said that his own country Ecuador would be economically battered by the pandemic and would need to “improve the purchasing processes” of medicines from India through government agreements.

The Ecuadorean envoy pointed out that generic drugs “can cost up to 10 times more” in South/Latin America than in India and therefore called for negotiating government agreements that allow them direct access to the Indian generic market. He added that Ecuador and other countries in the continent are therefore looking to emulate Costa Rica which is expecting to soon ink a government-to-government agreement to buy generic medicines without going through intermediaries that is estimated to save up to half of Costa Rica’s total medical costs that it has usually incurred for this.

 

It may be recalled that amid the coronavirus pandemic, India’s message to the rest of the world in the past few months has been that “India will be a reliable partner on medicines”.

From Latin and South America to the United States, across Africa, Europe, the Gulf region, South-east Asia, Australia and East Asia, it is a message that has resonated with India’s friends in their hour of need.

India had even declared that it has remained responsible in living up to its international commitments on the supply of medicines during the pandemic which has enhanced its reputation of being the “pharmacy to the world”. 

Tags: medicine production, coronavirus medicine, covid-19 medicine, generic pharmaceutical drugs, cheaper drugs, pharmacy of the world, covid medicine cost